[PMID: 38878351] PubMed record related to this compound for laboratory literature review
Reported Side Effects and Safety Concerns From Unlicensed Use Retatrutide causes predominantly gastrointestinal side effects, with additional class-level risks including pancreatitis, gallbladder disease, heart rate elevation, and injection site infections
Tirzepatide works by targeting two hormones in the body: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1)
Napier RJ, Rafi W, Cheruvu M, Powell KR, Zaunbrecher MA, Bornmann W, Salgame P, Shinnick TM, Kalman D
This breadth of application speaks to the fundamental nature of the healing processes that BPC-157 supports